[Drug industry and publication practice]

Ugeskr Laeger. 2011 Aug 15;173(33):1989.
[Article in Danish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Conflict of Interest
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Industry*
  • Editorial Policies
  • Glucagon-Like Peptide 1 / adverse effects
  • Glucagon-Like Peptide 1 / therapeutic use
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Peer Review, Research*
  • Periodicals as Topic*

Substances

  • Hypoglycemic Agents
  • Glucagon-Like Peptide 1